A Phase 1/2 interventional study of Coached exercise persistence intervention and Self-Monitored exercise persistence intervention in Pulmonary Disease, Chronic Obstructive, COPD and Emphysema, sponsored by University of Washington. Completed at 1 site in United States. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2009-12-07.
Sponsored by University of Washington · Phase 1/2 and Interventional
The purpose of this exploratory study is to determine the feasibility, acceptability, and efficacy of an exercise persistence intervention for patients with chronic obstructive pulmonary disease (COPD) following pulmonary rehabilitation (PR).
Exercise, a cornerstone of PR, is effective in improving dyspnea, functioning, and health related quality of life (HRQL) in patients with COPD. However, these improvements gradually dissipate following program completion. There are currently few successful interventions that support patients' persistence with community-based exercise after PR and that have closely monitored the potentially negative impact that COPD exacerbations have on exercise behaviors. Emerging technologies such as wirelessly enabled personal digital assistants (PDA) may provide an innovative means to support exercise persistence through real-time collaborative monitoring of exercise and signs and symptoms of COPD exacerbations and reinforcement to enhance exercise self-efficacy. Patient graduates of two PR programs who have COPD (n=20) will first undergo a 2-week run-in prior to being randomized to either the MOBILE (Mobilizing Support for Long-term Exercise) intervention or attention control for 6 months.
268 studies on the registry are indexed under Bronchitis; 26 are open to participants now.
This study's enrollment of 17 is below the median of 120 across 184 interventional studies indexed under Bronchitis.
Browse Bronchitis studies →University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.
Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Coached exercise persistence intervention
Behavioral: Coached exercise persistence intervention
Self-monitored exercise persistence intervention
Behavioral: Self-Monitored exercise persistence intervention
Collaborative symptom and exercise monitoring and weekly reinforcement for exercise persistence from nurse coach via a mobile device and telephone.
Self-monitoring of symptoms and exercise using a mobile device
Exercise behavior
Time frame: 3 & 6 Months
Self-efficacy for exercise
Time frame: 3 & 6 Months
Perception of support
Time frame: 3 & 6 Months
COPD exacerbation
Time frame: 3 & 6 Months
Exercise Performance
Time frame: 3 & 6 months
Health related quality of life
Time frame: 3 & 6 months
This study is completed, as verified in Dec 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Washington